June 21 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announce in ...

Lilly's orforglipron shows superior weight loss and blood sugar control Highest dose of the pill leads to 9.2% weight reduction Detailed trial results to be presented at future medical meeting The ...

Eli Lilly is scaling back its legacy insulin footprint in Europe, with plans to discontinue a swath of products for “commercial reasons.” The company is removing several of its insulin presentations, ...

A computer-generated image of a large manufacturing facility. A computer-generated image of Eli Lilly and Company’s planned drug chemical plant in Houston Credit: Eli Lilly and Company Eli Lilly and ...

Lilly is acquiring an exciting new program with the agreement to buy Verve Therapeutics. The terms of the deal mean there is still upside for investors, provided Lilly can take VERVE-102 to a phase 3 ...

Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now. There’s been huge hype around AI’s potential for drug discovery. But at Eli Lilly, ...

John Benjamin Hickey and Thomas Sadoski co-star. As the official synopsis teases, Lilly “discovers that the system has been cheating her, paying her close to half of what the men with the same job ...

The world’s largest drugmaker, Eli Lilly & Co., just notched another milestone: it’s the first health-care company to cross the $1 trillion threshold as investors bet big on the drugmaker’s ...

Eli Lilly will need an outstanding performance, likely driven by tirzepatide, to see its shares jump after its quarterly update on Feb. 4. Even if that doesn't happen, there are ample reasons to buy ...